GSK3B and ovarian carcinoma: One study identified S551, T555 and S589 as GSK-3β target sites based on kinase assays and experiments in hepatoma cells, while another study reported T498, S502, S505, T506, and S510 as GSK-3β sites in ovarian cancer cells [45,47].